Treatment of viral gastroenteritis
Pro Research Analysisby 
Searched over 200M research papers
Standard Treatment Approaches for Viral Gastroenteritis
The mainstay of treatment for viral gastroenteritis is supportive care, with a strong focus on rehydration. Oral rehydration therapy (ORT) using fluids that contain physiological concentrations of glucose and electrolytes is highly effective for children with mild-to-moderate dehydration and is as effective as intravenous (IV) fluids in these cases. IV therapy is reserved for severe dehydration or when oral rehydration fails. Routine laboratory tests are generally unnecessary unless the patient is severely dehydrated and requires hospitalization. Judicious use of antiemetic medications like ondansetron can help improve the success of oral rehydration and reduce the need for IV fluids and hospital admissions 25.
Avoidance of Unnecessary Medications and Polypharmacy
Following international guidelines, such as those from the WHO and ESPGHAN, helps avoid unnecessary use of antibiotics and other medications in children with viral gastroenteritis. Studies show that limiting treatment to diet therapy, oral rehydration, and infusion therapy only when indicated, reduces both the use of unnecessary drugs and the overall cost of care, without compromising outcomes 125.
Role of Probiotics in Symptom Relief
Probiotics have been shown to provide modest benefits in viral gastroenteritis. Meta-analyses and reviews indicate that probiotics can reduce the duration of diarrhea and shorten hospital stays in affected patients. These effects are generally mild but consistent, supporting the use of probiotics as an adjunct to standard supportive care 37.
Investigational and Adjunctive Therapies
Lactoferrin
Lactoferrin, a milk protein with antiviral properties, has shown potential in reducing the duration and severity of viral gastroenteritis in children, especially at higher doses. However, results from clinical trials are mixed, and more research is needed to confirm its effectiveness and optimal dosing .
Antiviral Drugs and Immunotherapies
Currently, there are no approved antiviral drugs specifically for the treatment of viral gastroenteritis in humans. Some studies have explored the use of technologically processed antibodies (such as Anaferon and Ergoferon) in children, reporting faster symptom resolution and good tolerability, but these findings are preliminary and require further validation 468. Research in animal models suggests that interferon-lambda (IFN-λ) can cure persistent norovirus infections, indicating a possible future direction for antiviral therapy, though this is not yet available for clinical use .
Prevention Strategies: Vaccines and Hygiene
Vaccination is a key preventive measure, especially against rotavirus, which is a leading cause of severe gastroenteritis in young children. Introduction of rotavirus vaccines has led to significant reductions in hospital admissions and deaths related to gastroenteritis in many countries. For norovirus, vaccines are still in development, but good hand hygiene and environmental disinfection remain essential preventive strategies 25.
Conclusion
The cornerstone of viral gastroenteritis treatment is supportive care with oral rehydration, reserving IV fluids for severe cases. Probiotics and possibly lactoferrin may offer additional symptom relief. Avoiding unnecessary medications is important to reduce costs and side effects. Vaccination and hygiene are crucial for prevention. While research into targeted antiviral therapies is ongoing, current management remains focused on supportive measures and prevention 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic
Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections
Antivirals identified in vitro and in vivo show potential against gastrointestinal viral infections, with organoid technologies aiding in the development of efficient therapies.
Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy
Targeting viral polymerase as an antiviral target could lead to a single broad-spectrum antiviral treatment for diarrhea-causing viruses, potentially benefiting children under five.
Potential effects of lactoferrin as antiviral and neoadjuvant therapy in pediatric patients with viral gastroenteritis
Lactoferrin supplements may reduce the duration and severity of pediatric viral gastroenteritis, but further studies using high doses are needed for further evaluation.
DOI